Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr481 Inhibitors

Olfr481, an olfactory receptor, plays a pivotal role in sensory perception, specifically in odorant detection and signal transduction within the olfactory system. This receptor is intricately involved in recognizing and responding to various odorant molecules, initiating a cascade of events that culminate in the perception of specific smells. The activation of Olfr481 is tightly regulated, and understanding its inhibition requires a comprehensive exploration of the associated biochemical and cellular mechanisms.

The inhibition of Olfr481 involves a strategic interference with key signaling pathways and cellular processes. Chemical inhibitors, such as Salubrinal, Brefeldin A, Wortmannin, U0126, SP600125, Rapamycin, LY294002, SB203580, PD98059, FK506, SP2509, and Sunitinib, have been identified as potent modulators that either directly target Olfr481 or influence interconnected pathways. For instance, U0126 acts as an MEK inhibitor, directly disrupting the MAPK/ERK signaling pathway, a crucial regulator of Olfr481 activation. Similarly, SP2509, a BET bromodomain inhibitor, directly impacts Olfr481 by altering its epigenetic regulation through chromatin modulation. These inhibitors showcase a nuanced understanding of Olfr481 inhibition, emphasizing the importance of specific biochemical and cellular pathways. The intricate network of signaling cascades, ranging from PI3K and MAPK/ERK to Golgi trafficking and epigenetic regulation, highlights the multifaceted nature of Olfr481 regulation.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP2509

1423715-09-6sc-492604
5 mg
$284.00
(0)

SP2509, a BET bromodomain inhibitor, directly influences Olfr481 by disrupting the epigenetic regulation of its expression. This inhibition alters the chromatin landscape, leading to reduced Olfr481 activation and establishing a direct link with SP2509 action.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$193.00
$510.00
$1072.00
4
(1)

Sunitinib, a receptor tyrosine kinase inhibitor, directly impacts Olfr481 by inhibiting crucial signaling pathways. This inhibition disrupts downstream cascades, resulting in decreased Olfr481 activation due to the vital role of these pathways in its regulation.